Could a COVID antiviral be the key to fighting long COVID?
NCT ID NCT05911906
Summary
This study tested whether a short course of the antiviral drug remdesivir could help reduce the ongoing symptoms of Long COVID. Researchers gave 73 adults with Long COVID the drug for five days and measured their symptoms before and after treatment. The main goal was to see if this approach was practical and acceptable to patients, to help plan a larger future trial.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Derbyshire Community Health Services NHS Foundation Trust
Chesterfield, S42 7JE, United Kingdom
-
Royal Derby Hospital (UHDB)
Derby, D22 3NE, United Kingdom
-
University of Derby
Derby, Derby, DE22 1GB, United Kingdom
-
University of Exeter / Royal Devon University Healthcare NHS FT
Exeter, EX4 4PY, United Kingdom
Conditions
Explore the condition pages connected to this study.